Mostrando ítems relacionados por Título, autor o materia.

• Clinical and Virologic Outcomes after Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network 

  Wolff, M.; Shepherd, B.E.; Cortés, C.; Rebeiro, P.; Cesar, C.; Wagner Cardoso, S.; Pape, J.W.; Padgett, D.; Sierra-Madero, J.; Echevarria Zarate, Juan Ignacio; McGowan, C.C.; CCASAnet (Wolters Kluwer Health, 2016)

  Background: HIV-infected persons in resource-limited settings may experience high rates of antiretroviral therapy (ART) change, particularly because of toxicity or other nonfailure reasons. Few reports address patient ...
• Time to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS in Latin America 

  Crabtree-Ramírez, B.; Caro-Vega, Y.; Shepherd, B.E.; Grinsztejn, B.; Wolff, M.; Cortes, C.P.; Padgett, D.; Carriquiry, G.; Fink, V.; Jayathilake, K.; Person, A.K.; McGowan, C.; Sierra-Madero, J.; CCASAnet (Public Library of Science, 2016)

  Background: Since 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an opportunistic infection (OI) has been recommended based on lower risks of death and AIDS-related progression found in ...
• Monitoring of HIV treatment in seven countries in the WHO region of the Americas 

  Belaunzarán-Zamudio, P.F.; Caro-Vega, Y.N.; Shepherd, B.E.; Crabtree-Ramírez, B.E.; Luz, P.M.; Grinsztejn, B.; Cesar, C.; Cahn, P.; Cortés, C.; Wolff, M.; Pape, J.W.; Padgett, D.; Gotuzzo Herencia, José Eduardo; McGowan, C.; Sierra-Madero, J.G.; CCASAnet (World Health Organization, 2015)

  Objective: To determine the prevalence of adequate monitoring and the costs of measuring CD4+ T-lymphocytes (CD4+ cell) and human immunodeficiency virus (HIV) viral load in people receiving antiretroviral therapy (ART) in ...